Neuropsychopharmacology: 5th Generation of Progress
by Kenneth L Davis, at al.
Publisher: Lippincott Williams & Wilkins 2002
Number of pages: 2080
Thoroughly updated and completely reorganized for a sharper clinical focus, the Fifth Edition of this world-renowned classic synthesizes the latest advances in basic neurobiology, biological psychiatry, and clinical neuropsychopharmacology. The book establishes a critical bridge connecting new discoveries in molecular and cellular biology, genetics, and neuroimaging with the etiology, diagnosis, and treatment of the full spectrum of neuropsychiatric disorders.
Home page url
Download or read it online for free here:
(multiple PDF files)
by Laura Meis, et al. - Department of Veterans Affairs
We conducted a systematic review of the published evidence evaluating if (and which) family involved treatments improve patient outcomes (i.e., efficacy) and if (and which) family involved treatments are superior to alternative interventions.
Schizophrenia is a chronic, severe, and disabling brain disorder that has affected people throughout history. Researchers are developing more effective medications and using new research tools to understand the causes of schizophrenia.
Depression is a common illness, and most who have it need treatment to get better. When a woman has a depressive disorder, it interferes with daily life, and causes pain for both the woman with the disorder and those who care about her.
- British Psychological Society
This guideline has been developed to advise on the treatment and management of attention deficit hyperactivity disorder. The guideline recommendations were developed by a multidisciplinary team of healthcare professionals, service users and carers.